Reports third quarter revenue of $1.0 billion, GAAP net loss of$(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to$1.6 - $2.0 billion Improves 2025 expected GAAP operating expenses by$0.7 billion to a range of $5.2 -$5.4 billion Increases 2025 expected year-end cash balance by $0.5 billion -$1 billion to a range of $6.5 -$7.0 billion CAMBRIDGE, MA / ACCESS Newswire / November 6, 2025 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates ...